bromocriptine 1mg tablets
a a h pharmaceuticals ltd - bromocriptine mesilate - oral tablet - 1mg
envarsus 1mg modified-release tablets
chiesi ltd - tacrolimus monohydrate - modified-release tablet - 1mg
ergotamine tartrate, caffeine tablet
kmm pharmaceuticals, llc - ergotamine tartrate (unii: mru5xh3b48) (ergotamine - unii:pr834q503t), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - ergotamine tartrate and caffeine tablets are indicated as therapy to abort or prevent vascular headache; e.g., migraine, migraine variants or so-called “histaminic cephalalgia.” coadministration of ergotamine with potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see precautions: drug interactions ), with some cases resulting in amputation. there have been rare reports of cerebral ischemia in patients on protease inhibitor therapy when ergotamine tartrate and caffeine tablets was coadministered, at least one resulting in death. because of the increased risk of ergotism and other serious vasospastic adverse events, ergotamine use is contraindicated with these drugs and other potent inhibitors of cyp 3a4 (e.g., ketoconazole, itraconazole) (see warnings: cyp 3a4 inhibitors ). ergotamine tartrate and caffeine tablets may cause fetal
pergolide 1mg tablets
waymade healthcare plc - pergolide mesilate - oral tablet - 1mg
pergolide 1mg tablets
alliance healthcare (distribution) ltd - pergolide mesilate - oral tablet - 1mg
pergolide 1mg tablets
genus pharmaceuticals ltd - pergolide mesilate - oral tablet - 1mg
pergolide 1mg tablets
kent pharma (uk) ltd - pergolide mesilate - oral tablet - 1mg
pergolide 1mg tablets
sandoz ltd - pergolide mesilate - oral tablet - 1mg
pergolide 1mg tablets
sigma pharmaceuticals plc - pergolide mesilate - oral tablet - 1mg
pergolide 1mg tablets
phoenix healthcare distribution ltd - pergolide mesilate - oral tablet - 1mg